Can Lorazepam Cause Headaches?
Yes, lorazepam can cause headaches as a recognized adverse effect, though the mechanism and frequency vary depending on the clinical context.
Direct Adverse Effect
Headache is listed as an adverse reaction in the FDA-approved lorazepam drug label 1. While the exact incidence is not quantified in the prescribing information, headaches appear among the documented CNS effects of benzodiazepines, which are generally dose-dependent 1.
Clinical Context: Withdrawal vs. Active Use
The relationship between lorazepam and headaches is bidirectional and context-dependent:
During Active Treatment
- Headache can occur as a direct side effect during lorazepam use 1
- A recent 2025 case report documented secondary headaches developing after lorazepam initiation, specifically evening headaches that were dose-related (worse on 2 mg vs. 1 mg nights) and associated with orthostatic symptoms 2
- The mechanism may involve orthostatic intolerance and autonomic dampening, particularly in patients with baseline low blood pressure 2
During Withdrawal
- Headache is a cardinal feature of benzodiazepine withdrawal syndrome 3
- The withdrawal syndrome typically includes headache along with sleep disturbance, anxiety, tremor, sweating, and perceptual changes 3
- This occurs within 1-4 days of discontinuation depending on the drug's half-life 3
- Withdrawal symptoms can persist for 10-14 days in the full-blown syndrome, or even weeks to months in protracted cases 3
Paradoxical Association with Migraine
Importantly, short-acting benzodiazepines like lorazepam are associated with increased migraine occurrence 4. A 2017 nationwide population-based study found:
- Adjusted odds ratio of 1.69 (95% CI 1.59-1.80) for migraine in patients using short-acting benzodiazepines alone 4
- Even higher risk (OR 2.06) when combining short- and long-acting benzodiazepines 4
- This association was not seen with long-acting benzodiazepines alone 4
Clinical Implications
When Headaches Occur During Lorazepam Use:
- Assess timing: New-onset headaches after starting lorazepam suggest direct drug effect
- Check orthostatic vital signs: Measure blood pressure and heart rate supine and standing, especially in patients with baseline low blood pressure 2
- Review total anticholinergic burden: Co-administration with tricyclic antidepressants or antihistamines increases risk 2
- Evaluate hydration status: Relative dehydration can amplify symptoms 2
When Headaches Occur After Stopping:
- Consider withdrawal syndrome: Headache within 1-4 days of discontinuation strongly suggests withdrawal 3
- Do not abruptly discontinue: Gradual taper is essential to minimize withdrawal symptoms 1
- Monitor for other withdrawal features: Anxiety, tremor, insomnia, perceptual changes 3
Common Pitfalls to Avoid
- Do not dismiss new headaches in lorazepam users as unrelated—they may be drug-induced
- Do not abruptly stop lorazepam in patients with chronic use, as this can precipitate severe withdrawal headaches and other serious symptoms 1
- Do not use lorazepam for migraine treatment—despite its use in some clinical settings for agitation 5, 6, benzodiazepines are not recommended for migraine management and may paradoxically increase migraine occurrence 4
- Avoid overlooking orthostatic symptoms that may accompany lorazepam-induced headaches, particularly in patients with low baseline blood pressure 2
Management Approach
If headaches develop during lorazepam treatment:
- Consider dose reduction rather than immediate discontinuation
- Optimize hydration and salt intake 2
- Reduce total anticholinergic medication burden 2
- Monitor orthostatic vital signs with symptom logging 2
- Consider alternative treatments for the underlying indication (e.g., CBT-I for insomnia) 2
If headaches occur during withdrawal:
- Resume lorazepam at previous dose and implement gradual taper
- Provide supportive care during controlled withdrawal
- Consider adjunctive treatments for withdrawal symptoms as clinically appropriate
The evidence clearly establishes that lorazepam can cause headaches both as a direct adverse effect during treatment and as a prominent feature of withdrawal syndrome, with additional epidemiological data linking short-acting benzodiazepines to increased migraine risk.